Curr Pain Headache Rep 2022 Jun 25. Epub 2022 Jun 25.
Lewis Headache Center, Department of Neurology, Barrow Neurological Institute | St Joseph Health Center, 350 W. Thomas Rd, AZ, 85013, Phoenix, USA.
Purpose Of Review: The authors present data on cardiovascular safety for the new acute and preventive migraine treatments including ditans, gepants, and calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) alongside older medications like triptans and ergotamines.
Recent Findings: The authors conclude that there are no cardiovascular safety concerns for lasmiditan, and that it could be used in those with cardiovascular disease. In fact, the literature even suggests that triptans are safer in cardiovascular disease than their contraindications may suggest. Read More